Author: Chris Albert

I am a senior reporter for the Business d’Or breaking news team, covering health and science.

A new study from Queen Mary University of London has found a way to predict dementia much earlier. Experts think it could be about 80% accurate and up to nine years before someone shows signs of dementia. Professor Charles Marshall and his team used functional MRI (fMRI) scans to study changes in the brain’s ‘default mode network’ (DMN). They believe this method is more accurate than memory tests or checking for brain shrinkage in predicting dementia. Early Signs of Dementia Can Be Predicted With High Accuracy Scientists, used fMRI scans from more than 1,100 volunteers in the UK Biobank, which…

Read more

Exposure to elevated levels of air pollution and noise pollution during pregnancy, early childhood, and adolescence has been linked to increased occurrences of psychotic experiences, depression, and anxiety, according to a new study published in JAMA Network Open. The research also indicated that exposure to fine particulate matter, known as PM2.5, may be associated with a higher prevalence of depression. Additionally, during pregnancy, exposure to PM2.5 was correlated with children experiencing more psychotic episodes. “Early-life exposure could be detrimental to mental health given the extensive brain development and epigenetic processes that occur in utero and during infancy. Air pollution could…

Read more

The meteoric rise of weight loss drugs means consumers’ nutritional needs are “shifting” which provides new opportunities for food companies, according to Nestle CEO Mark Schneider in an interview with CNBC. Initially, investors expressed concerns about the impact of GLP-1 drugs like Wegovy and Ozempic on food consumption, assuming that individuals using these drugs would eat less, Schneider explained. However, this perspective has evolved over time. Schneider noted that while consumers on weight loss medication have different nutritional needs, those needs do not disappear. Instead, they change. Whether before, during, or after GLP-1 therapy, individuals still require essential nutrients, but…

Read more

In a major clinical trial, semaglutide, the compound found in the blockbuster drugs Ozempic and Wegovy, significantly reduced the risk of kidney complications, heart issues, and death in individuals with Type 2 diabetes and chronic kidney disease. The results, published on Friday, could revolutionize the treatment of chronic kidney disease, which affects over one in seven adults in the United States and currently has no cure. “We who truly care about kidney patients have dedicated our entire careers to seeking better treatments,” said Dr. Katherine Tuttle, a professor of medicine at the University of Washington School of Medicine and a…

Read more

On Sunday, Elon Musk and Indonesian Health Minister Budi Gunadi Sadikin inaugurated SpaceX’s satellite internet service for the nation’s health sector, with the goal of enhancing access in the remote areas of the expansive archipelago. Musk, the billionaire CEO of SpaceX and Tesla, arrived by private jet on the Indonesian resort island of Bali. He then attended the launch ceremony at a community health center in Denpasar, the provincial capital. Musk, dressed in a green batik shirt, stated that the introduction of Starlink service in Indonesia would enable millions of people in remote areas to access the internet. Indonesia, with…

Read more

On Friday, Novavax announced the signing of a multibillion-dollar agreement with the French pharmaceutical company Sanofi. The deal involves jointly commercializing Novavax’s Covid vaccine from next year onwards and collaborating on the development of combination vaccines aimed at both coronavirus and influenza, alongside other initiatives. Novavax shares surged by 120% in premarket trading on Friday compared to their previous day’s closing price of $4.47 per share. Novavax CEO John Jacobs informed CNBC during an interview that the licensing agreement will enable the company to remove its “going concern” warning. This warning was initially issued in February 2023 due to concerns…

Read more

Paul Alexander, who spent most of the last 70 years in an iron lung and defied expectations by becoming a lawyer and author, died Monday afternoon at the age of 78, according to his brother Philip Alexander. His death was announced Tuesday on a GoFundMe page created to help pay for his housing and health care. “It is absolutely incredible to read all the comments and know that so many people were inspired by Paul. I am just so grateful,” Philip expressed on the GoFundMe page. The exact cause of Paul’s passing remains unclear. Although he was hospitalized three weeks ago due…

Read more

Elon Musk, the founder of Neuralink, mentioned that a person with their brain technology implanted can control a computer mouse simply by thinking. Musk shared in a conversation on social media that the patient appears to have fully recovered without any negative effects that they know of and is capable of moving the mouse around the screen using only their thoughts. Neuralink’s Journey to Help People Control Devices Neuralink is a startup owned by a billionaire. They claim to have created a brain implant to help people use their brain signals to control outside devices. The company wants to help…

Read more

Elon Musk’s company Neuralink recently placed its brain implant in a person for the first time. Musk shared on X (previously known as Twitter) that the patient is doing well. Neuralink is working on a brain implant to assist people with serious paralysis in controlling devices through their neural signals. The company started recruiting participants for its first human trial in the fall after getting approval from the U.S. Food and Drug Administration in May, as mentioned in a blog post. Neuralink’s Telepathy On Monday, Musk mentioned on X that Neuralink’s initial product is named Telepathy. If the technology works…

Read more